FiercePharma15h
Neurocrine's Crenessity ends 70-year drought with FDA nod for rare genetic disease
After seven decades with no advances in the treatment of the genetic disorder classic congenital adrenal hyperplasia (CAH), ...
pharmaphorum16h
FDA clears Neurocrine drug for rare adrenal disorder
The FDA has approved Neurocrine Bioscience's Crenessity for classic congenital adrenal hyperplasia (CAH), the first drug for ...